🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ryan O. Milligan

Queen's University Belfast

ORCID: 0000-0001-5031-1892

Physics and AstronomyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study”.

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The Lancet HIV(2024)10.1016/s2352-3018(23)00300-4

N/A

1.1DataRank · unranked

29 citations

Edmund V. Capparelli, Katherine Calabrese, Kristin Baltrusaitis, Mark A. Marzinke, Cynthia McCoig +36 more

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study

The Lancet HIV(2024)10.1016/s2352-3018(23)00301-6

N/A

0.959DataRank · unranked

26 citations

Jennifer Chapman, Rachel Ohrenschall, Katherine Calabrese, Kristin Baltrusaitis, Barbara Heckman +32 more

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The Lancet HIV(2025)10.1016/s2352-3018(24)00344-8

N/A

0.535DataRank · unranked

12 citations

Kristin Baltrusaitis, Brookie M. Best, Jack Moye, Ellen Townley, Avy Violari +36 more

Immunopeptidomics informs discovery and delivery of Mycobacterium tuberculosis MHC-II antigens for vaccine design

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.02.616386

N/A

0.165DataRank · unranked

2 citations

Paul Ogongo, Julia Huffaker, Mingyu Gan, Ryan O. Milligan, Sheikh Mahmud +9 more